Analysis of Exonic Regions Involved in Nuclear Localization, Splicing Activity, and Dimerization of Muscleblind-like-1 Isoforms

Archive ouverte

Tran, Helene | Gourrier, Nathalie | Lemercier-Neuillet, Camille | Dhaenens, Claire-Marie | Vautrin, Audrey | Fernandez-Gomez, Francisco, José | Arandel, Ludovic | Carpentier, Celine | Obriot, Hélène | Eddarkaoui, Sabiha | Delattre, Lucie | van Brussels, Edwige | Holt, Ian | Morris, Glenn, E | Sablonnière, Bernard | Buée, Luc | Charlet-Berguerand, Nicolas | Schraen-Maschke, Susanna | Furling, Denis | Behm-Ansmant, Isabelle | Branlant, Christiane | Caillet-Boudin, Marie-Laure | Sergeant, Nicolas

Edité par CCSD ; American Society for Biochemistry and Molecular Biology -

International audience. Muscleblind-like-1 (MBNL1) is a splicing regulatory factor controlling the fetal-to-adult alternative splicing transitions during vertebrate muscle development. Its capture by nuclear CUG expansions is one major cause for type 1 myotonic dystro-phy (DM1). Alternative splicing produces MBNL1 isoforms that differ by the presence or absence of the exonic regions 3, 5, and 7. To understand better their respective roles and the consequences of the deregulation of their expression in DM1, here we studied the respective roles of MBNL1 alternative and constitu-tive exons. By combining genetics, molecular and cellular approaches, we found that (i) the exon 5 and 6 regions are both needed to control the nuclear localization of MBNL1; (ii) the exon 3 region strongly enhances the affinity of MBNL1 for its pre-mRNA target sites; (iii) the exon 3 and 6 regions are both required for the splicing regulatory activity, and this function is not enhanced by an exclusive nuclear localization of MBNL1; and finally (iv) the exon 7 region enhances MBNL1-MBNL1 dimerization properties. Consequently, the abnormally high inclusion of the exon 5 and 7 regions in DM1 is expected to enhance the potential of MBNL1 of being sequestered with nuclear CUG expansions, which provides new insight into DM1 pathophysiology.

Suggestions

Du même auteur

Comment les acteurs moléculaires de la pathologie Alzheimer permettent de comprendre la démence ? Quelles conséquences diagnostiques et thérapeutiques ?

Archive ouverte | Buée, Luc | CCSD

International audience

Myotonic Dystrophy: an RNA Toxic Gain of Function Tauopathy?

Archive ouverte | Fernandez-Gomez, Francisco, J. | CCSD

International audience

MBNL1 gene variants as modifiers of disease severity in myotonic dystrophy type 1

Archive ouverte | Huin, Vincent | CCSD

International audience. Myotonic dystrophy type 1 (DM1) is a multisystemic autosomal dominant disorder characterized by a highly variable phenotype and caused by an unstable CTG repeat expansion in the 3' untranslat...

Chargement des enrichissements...